Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012803
Filing Date
2025-05-13
Accepted
2025-05-13 17:05:28
Documents
1
Period of Report
2025-05-09

Document Format Files

Seq Description Document Type Size
1 form4-05132025_050524.html 4  
1 form4-05132025_050524.xml 4 4430
  Complete submission text file 0001415889-25-012803.txt   5815
Mailing Address 2331 CITYWEST BLVD #N1345-04 HOUSTON TX 77042
Business Address
TILTON GLENN F (Reporting) CIK: 0001194624 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 25941227

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)